Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Next wave of successful drug therapy strategies in HER2-positive breast cancer

Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium
Next wave of successful drug therapy strategies in HER2-positive breast cancer ( Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium )
15 May 2013

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013

How do we design trials that improve outcome?

Dr Lisa Carey - University of North Carolina, Chapel Hill, USA
How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )
15 May 2013

Breast cancer heterogeneity no barrier to predictive testing

Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland
Breast cancer heterogeneity no barrier to predictive testing ( Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )
15 May 2013

Measurement variation influences gene expression profiles of breast cancer

Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA
Measurement variation influences gene expression profiles of breast cancer ( Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013

Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab

Dr Yanina Dockx - University of Antwerp, Edegem, Belgium
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2  breast cancer resistant to trastuzumab ( Dr Yanina Dockx - University of Antwerp, Edegem, Belgium )
15 May 2013

The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer

Prof Charles Perou - University of North Carolina School of Medicine, USA
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer ( Prof Charles Perou - University of North Carolina School of Medicine, USA )
14 May 2013

Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
14 May 2013

Long-term effectiveness of SERMs for preventing breast cancer

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Long-term effectiveness of SERMs for preventing breast cancer ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
14 May 2013

Involvement in the WIN Consortium

Dr Gary Palmer, Dr Lia Tsimberidou and Dr Gerald Batist
Involvement in the WIN Consortium ( Dr Gary Palmer, Dr Lia Tsimberidou and Dr Gerald Batist )
30 Apr 2013

The 2013 WIN Symposium

Prof Josep Tabernero and Dr Gerald Batist
The 2013 WIN Symposium ( Prof Josep Tabernero and Dr Gerald Batist )
30 Apr 2013

Implementation of individualised treatment and the WINTHER trial

Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Implementation of individualised treatment and the WINTHER trial ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013